Wellington Management Group LLP于2026年8月13日以每股均价31.4819港元买入劲方医药-B股份2.88万股,涉资约90.67万港元。
Wellington Management Group LLP此次增持前持有劲方医药-B好仓2459.98万股,占比6.99%;增持后持股量为2462.86万股,好仓比例升至7.0%。
Wellington Management Group LLP于2026年8月13日以每股均价31.4819港元买入劲方医药-B股份2.88万股,涉资约90.67万港元。
Wellington Management Group LLP此次增持前持有劲方医药-B好仓2459.98万股,占比6.99%;增持后持股量为2462.86万股,好仓比例升至7.0%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.